The use of luminescence in biological systems allows one to diagnose diseases and understand cellular processes. Molecular systems, particularly lanthanide(III) complexes, have emerged as an attractive system for application in cellular luminescence imaging due to their long emission lifetimes, high brightness, possibility of controlling the spectroscopic properties at the molecular level, and tailoring of the ligand structure that adds sensing and therapeutic capabilities. This review aims to provide a background in luminescence imaging and lanthanide spectroscopy and discuss selected examples from the recent literature on lanthanide(III) luminescent complexes in cellular luminescence imaging, published in the period 2016–2020. Finally, the challenges and future directions that are pointing for the development of compounds that are capable of executing multiple functions and the use of light in regions where tissues and cells have low absorption will be discussed.
26 July 2016 in Angewandte Chemie International Edition
The use of luminescence in biological systems allows us to diagnose diseases and understand cellular processes. Persistent luminescent materials have emerged as an attractive system for application in luminescence imaging of biological systems; the afterglow emission grants background-free luminescence imaging, there is no need for continuous excitation to avoid tissue and cell damage due to the continuous light exposure, and they also circumvent the depth penetration issue caused by excitation in the UV-Vis. This review aims to provide a background in luminescence imaging of biological systems, persistent luminescence, and synthetic methods for obtaining persistent luminescent materials, and discuss selected examples of recent literature on the applications of persistent luminescent materials in luminescence imaging of biological systems and photodynamic therapy. Finally, the challenges and future directions, pointing to the development of compounds capable of executing multiple functions and light in regions where tissues and cells have low absorption, will be discussed.
The ligands 4-fluorobenzoate (4-fba), 4-chlorobenzoate (4-cba), 4-bromobenzoate (4-bba) and 4-iodobenzoate (4-iba) were chosen in order to synthesize europium(III), gadolinium(III) and terbium(III) complexes and compare the effect of halogens on their physical chemistry and luminescent properties. The homobimetallic complex [Eu(4-iba)3(H2O)(dmf)]2 crystallizes in the monoclinic P21/c space group with unit cell parameters a = 8.3987(9) Å, b = 25.314(3) Å, c = 14.1255(17) Å, and β = 105.347(2)°. FTIR spectroscopy indicates that the bidentate bridging mode of the carboxylato ligand was present in all complexes while bidentate chelate and a mixture of bidentate bridging and chelate modes were also found. According to emission spectra profiles and the Judd–Ofelt parameters the halogen of ligand molecules modifies the chemical environment symmetry around the europium(III) ion in their respective complexes. The complexes [Eu(4-fba)3(H2O)2] and [Eu(4-iba)3(H2O)2] have the highest symmetry around the europium(III) while the complexes [Eu(4-cba)3]·2H2O, [Eu(4-bba)3]·5/2H2O and [Eu(4-iba)3(H2O)(dmf)]2 have the lowest. The different halogens at the para position do not change the covalence degree of Eu–O bonds significantly, however they play a role in the ligand to metal charge transfer energies. The highest non-radiative energy transfer rates from ligand to europium(III) were found for the complexes [Eu(4-cba)3]·2H2O and [Eu(4-bba)3]·5/2H2O.